[1]
2021. Conjunctivitis in Tralokinumab-Treated Adult Patients with Moderate-To-Severe Atopic Dermatitis: Pooled Results from Five Clinical Trials. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s10. DOI:https://doi.org/10.25251/skin.5.supp.10.